Literature DB >> 26669469

Aerobic Glycolysis and the Warburg Effect. An Unexplored Realm in the Search for Fibrosis Therapies?

Toby M Maher1,2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26669469      PMCID： PMC4731726          DOI： 10.1164/rccm.201508-1699ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

Review 1.  The key role of anaplerosis and cataplerosis for citric acid cycle function.

Authors:  Oliver E Owen; Satish C Kalhan; Richard W Hanson
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

Review 2.  Host-gut microbiota metabolic interactions.

Authors:  Jeremy K Nicholson; Elaine Holmes; James Kinross; Remy Burcelin; Glenn Gibson; Wei Jia; Sven Pettersson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

3.  Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation.

Authors:  Stephanos Pavlides; Aristotelis Tsirigos; Iset Vera; Neal Flomenberg; Philippe G Frank; Mathew C Casimiro; Chenguang Wang; Paolo Fortina; Sankar Addya; Richard G Pestell; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-06-01       Impact factor: 4.534

4.  18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials.

Authors:  Thida Win; Tryphon Lambrou; Brian F Hutton; Irfan Kayani; Nicholas J Screaton; Joanna C Porter; Toby M Maher; Raymondo Endozo; Robert I Shortman; Pauline Lukey; Ashley M Groves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-30       Impact factor: 9.236

5.  Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.

Authors:  Na Xie; Zheng Tan; Sami Banerjee; Huachun Cui; Jing Ge; Rui-Ming Liu; Karen Bernard; Victor J Thannickal; Gang Liu
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

6.  Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model.

Authors:  Moisés Selman; Annie Pardo
Journal:  Am J Respir Crit Care Med       Date:  2014-05-15       Impact factor: 21.405

7.  The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.

Authors:  Phillip L Molyneaux; Michael J Cox; Saffron A G Willis-Owen; Patrick Mallia; Kirsty E Russell; Anne-Marie Russell; Elissa Murphy; Sebastian L Johnston; David A Schwartz; Athol U Wells; William O C Cookson; Toby M Maher; Miriam F Moffatt
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 30.528

8.  Fructose-1,6-bisphosphatase opposes renal carcinoma progression.

Authors:  Bo Li; Bo Qiu; David S M Lee; Zandra E Walton; Joshua D Ochocki; Lijoy K Mathew; Anthony Mancuso; Terence P F Gade; Brian Keith; Itzhak Nissim; M Celeste Simon
Journal:  Nature       Date:  2014-07-20       Impact factor: 49.962

9.  Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis.

Authors:  Simone Cardaci; Liang Zheng; Gillian MacKay; Niels J F van den Broek; Elaine D MacKenzie; Colin Nixon; David Stevenson; Sergey Tumanov; Vinay Bulusu; Jurre J Kamphorst; Alexei Vazquez; Stewart Fleming; Francesca Schiavi; Gabriela Kalna; Karen Blyth; Douglas Strathdee; Eyal Gottlieb
Journal:  Nat Cell Biol       Date:  2015-08-24       Impact factor: 28.824

10.  Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients.

Authors:  Thida Win; Benjamin A Thomas; Tryphon Lambrou; Brian F Hutton; Nicholas J Screaton; Joanna C Porter; Toby M Maher; Raymondo Endozo; Robert I Shortman; Asim Afaq; Pauline Lukey; Peter J Ell; Ashley M Groves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-14       Impact factor: 9.236
View more
  7 in total

1.  Redox Imbalance in Idiopathic Pulmonary Fibrosis: A Role for Oxidant Cross-Talk Between NADPH Oxidase Enzymes and Mitochondria.

Authors:  Carmen Veith; Agnes W Boots; Musa Idris; Frederik-Jan van Schooten; Albert van der Vliet
Journal:  Antioxid Redox Signal       Date:  2019-04-05       Impact factor: 8.401

2.  Renoprotection of Microcystin-RR in Unilateral Ureteral Obstruction-Induced Renal Fibrosis: Targeting the PKM2-HIF-1α Pathway.

Authors:  Yan Ren; Jie Wang; Wenwen Guo; Jingwen Chen; Xin Wu; Shubo Gu; Lizhi Xu; Zhiwei Wu; Yaping Wang
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

Review 3.  Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge.

Authors:  Wiwin Is Effendi; Tatsuya Nagano
Journal:  Int J Mol Sci       Date:  2022-05-28       Impact factor: 6.208

Review 4.  A New Hypothetical Concept in Metabolic Understanding of Cardiac Fibrosis: Glycolysis Combined with TGF-β and KLF5 Signaling.

Authors:  Thanachai Methatham; Ryozo Nagai; Kenichi Aizawa
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

5.  [18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.

Authors:  Aurélien Justet; Astrid Laurent-Bellue; Gabriel Thabut; Arnaud Dieudonné; Marie-Pierre Debray; Raphael Borie; Michel Aubier; Rachida Lebtahi; Bruno Crestani
Journal:  Respir Res       Date:  2017-04-27

6.  18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study.

Authors:  Emmanuel Ledoult; Maxime Morelle; Clio Baillet; David Launay; Michael Soussan; Arsène Mékinian; Hélène Béhal; Vincent Sobanski; Eric Hachulla; Damien Huglo; Noémie Le Gouellec; Martine Remy-Jardin
Journal:  Arthritis Res Ther       Date:  2021-03-06       Impact factor: 5.156

Review 7.  Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics.

Authors:  Daniel C Zank; Marta Bueno; Ana L Mora; Mauricio Rojas
Journal:  Front Med (Lausanne)       Date:  2018-02-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.